Skip to main content
letter
. 2021 Apr 1;106(8):2277–2280. doi: 10.3324/haematol.2021.278301

Figure 2.

Figure 2.

Mutational profiles of 14 patients in this trial. Samples for 14 patients, including four pairs of sequentially acquired samples, were subjected to targeted sequencing encompassing 120 lymphoma-associated genes. *Patient SNU22 was initially diagnosed as having extranodal NK/T-cell lymphoma according to the patient’s referral record from another hospital. CR: complete remission; PR: partial remission; SD: stable disease; PD: progressive disease; AITL: angioimmunoblastic T-cell lymphoma; PTCL: peripheral T-cell lymphoma; ENKTCL: extranodal NK/T-cell lymphoma, nasal type; EBV+ LPD: Epstein-Barr virus-positive Tcell lymphoproliferative disorders.